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A Mutated EGFR Is Sufficient to Induce Malignant
Melanoma with Genetic Background-Dependent
Histopathologies
Manfred Schartl1, Brigitta Wilde1, Juliette AGC Laisney1, Yoshihito Taniguchi2, Shunichi Takeda2 and
Svenja Meierjohann1
Melanoma is a tumor with a very low cure rate once metastasized. Although many genes important for
melanoma induction, transformation, and metastasis have been identified, the process of melanomagenesis is
only partly understood. Melanoma mediators are easiest to investigate in cell culture models, but animal
models are required to evaluate their importance in the context of the whole organism. Here, we describe a
transgenic melanoma model in medaka. The oncogenic receptor tyrosine kinase, Xmrk, responsible for
melanoma formation in Xiphophorus, was stably expressed under the control of a pigment cell-specific
promoter. The transgenic fish developed pigment cell tumors with a penetrance of 100%. The model was used
for monitoring the in vivo relevance of several apoptosis and differentiation genes, and for induction of
melanoma-relevant signal transduction pathways. We found that Stat5 activation, and Mitf and Bcl-2 levels
correlated with a more aggressive stage of the malignancy. Interestingly, different types of pigment cell tumors
occurred depending on the genetic background, namely invasive melanoma, uveal melanoma, or exophytic and
less aggressive pigment cell tumors called xanthoerythrophoroma. Furthermore, on p53 mutant background,
the expression of xmrk led to the appearance of giant focal pigment cell tumors, whereas tumor onset was
unchanged compared with wild-type medaka.
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INTRODUCTION
Malignant melanoma in humans shows a steady increase in
incidence and still remains one of the deadliest cancers, with
a 5-year survival rate of less than 20%. A number of genes
have been identified that can be ascribed a critical role
during development of the disease, at least in a subset of
various types of melanoma, such as NRAS, BRAF, PTEN,
CDKN2A, CTNNB1 (b-catenin), and GNAQ (Castellano and
Parmiani, 1999; Chin, 2003; Van Raamsdonk et al., 2009).
To understand, in detail, the function of these genes for
melanoma development and the molecular processes under-
lying transformation of a normal pigment cell into a fully
malignant melanoma cell, animal models can make a useful
contribution. Transgenic models have the advantage that the
primary effects elicited by the tumor-inducing gene can be
separated from the contribution of the genetic background.
As efficient therapies are urgently needed, animal models can
also be used for target validation and high-throughput drug
screening.
One of the oldest animal models for human cancer are
Xiphophorus fish, in which spontaneous melanoma forma-
tion occurs specifically in certain hybrid genotypes. Here,
overexpression of a mutated version of the EGF receptor,
called Xmrk, causes development of malignant tumors (for
review see Meierjohann and Schartl, 2006). The signal
transduction events downstream of Xmrk are reasonably well
understood. It is, however, unclear to what extent the hybrid
genetic background and potential ‘‘tumor modifiers’’ con-
tribute to Xmrk-induced tumorigenesis. In addition, further
studies, especially large-scale high-throughput approaches,
are hampered by the fact that this fish is live-bearing and
transgenic approaches are not available. In the medaka, no
natural occurring tumor model has been found, but this
species offers all advantages of small-animal experimental
systems. Similar to zebrafish, it is easy to breed in large
numbers, it produces externally developing transparent
embryos, and available transgenic technologies provide easy
means to modify the genome (Wittbrodt et al., 2002; Thermes
et al., 2002). In addition, a number of in vitro systems have
been established, including embryonic stem cell-like and
spermatogonial stem cell lines (Hong et al., 1998; Hong
et al., 2004). The full genome has been sequenced (Kasahara
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et al., 2007) and large-scale mutagenesis screens have
uncovered numerous mutants with interesting phenotypes
(Furutani-Seiki et al., 2004). Such mutants can be exploited in
search for genetic modifiers, as it was done in the zebrafish
model (Pei et al., 2007; Yeyati et al., 2007). Furthermore,
established methods, such as tilling, offer the possibility to
access genetic changes that modify the observed phenotype
(Sood et al., 2006).
For medaka, there is a fair collection of already described
pigmentation mutants available, which can complement the
analogous zebrafish collection (Kelsh et al., 2004; Pickart
et al., 2004; Lynn Lamoreux et al., 2005). In both fish models,
this offers the opportunity to monitor melanoma development
in a pigmentation mutant context and thereby elucidate
whether in addition to the pigment cell-specific transcription
factor, microphthalmia-associated transcription factor (Mitf),
as described for human melanoma (Du et al., 2004; Carreira
et al., 2006; Wellbrock et al., 2008), other pigment cell-
specific genes also contribute to melanoma development.
We therefore aimed at using the advantages of the medaka
by transferring xmrk-dependent melanoma development
from Xiphophorus to this species. By using a pigment cell-
specific promoter, we obtained several stable transgenic
medaka lines that spontaneously develop malignant melano-
ma with 100% penetrance. Analysis of these lines uncovered
the existence of tumor modifier genes in the medaka genome
and pointed out melanoma-relevant intracellular signaling
events.
RESULTS
Melanoma formation in transgenic medaka
In the Xiphophorus melanoma model, tumorigenic expres-
sion of xmrk occurs only in melanocytes. However, previous
analyses have shown that xmrk is a potent oncogene that can
also transform a variety of other cell types (Winkler et al.,
1994; Winnemoeller et al., 2005). Owing to this, the
generation of a transgenic melanoma model critically
depended on a pigment cell-specific promoter to drive xmrk
expression. Thus, the mitfa promoter from medaka was fused
to the full-length cDNA of the Xiphophorus xmrk oncogene.
Embryos (strains Carbio and albino (i-3)) injected with this
construct developed a number of abnormalities due to the
activity of the transgene. Frequently, single abnormally large
pigment cells, whose morphology resembled the typical
macromelanophores of Xiphophorus, were noted. Whether
these large pigment cells are multinucleated and arise
through Xmrk-driven endomitosis, as shown in murine
melanocytes (Leikam et al., 2008), remains to be addressed.
Importantly, this cell type does not occur in non-xmrk-
transgenic medaka. Some embryos showed large black
patches of hyperpigmentation at 5–6 days of development
(Supplementary Figure S1). Other embryos developed three-
dimensional growth of darkly pigmented cells, which were
histologically classified as melanotic tumors (data not
shown). None of these fish hatched and survived.
Some of the injected fish developed, as juvenile or adult
animals, large areas of hyperpigmentation or progressively
growing pigment cell tumors. Besides melanoma, pigment
cell tumors of the red and yellow pigment-containing
xanthophores and erythrophores (so called xanthoerythro-
phoromas or XE tumors) also developed (Figure 1a), some-
times even on the same individual.
The melanotic tumors showed highly invasive growth,
penetrating mainly into the body musculature and also into
internal organs. In some fish, the tumors started to develop
from the chorioidea of the eye, from the spinal cord or from
the intestine (Figure 1b–d, Supplementary Figure S2). In fish,
these organs harbor extracutaneous melanocytes, apparently
giving rise to the observed melanoma.
Importantly, melanoma tissue was also detected at sites,
which are normally devoid of extracutaneous pigment cells,
for example, the liver (Figure 1c, lower left and Supplemen-
tary Figure S2). Histological analysis from serial sections
revealed that the tumors had no connection to the main
tumor mass and can, therefore, be regarded as metastases.
The melanotic lesions showed different degrees of
pigmentation. The more aggressive melanomas were always
less melanized, with large fractions of undifferentiated cells
exhibiting nuclear pleomorphisms similar to human melano-
ma. Both xanthoerythrophoromas and melanomas were
composed of densely packed cells with pleomorphic nuclei,
eventually invading the underlying musculature. Isolated
nests of melanized cells were regularly seen in these
neoplasms (Figure 1a, bottom).
On ultrastructural level, the presence of premelanosomes
as predominant organelles confirmed the low degree of
melanoma cell differentiation. Cells were also characterized
by the typical irregularly shaped lobulated nuclei exhibiting
nuclear pockets (Figure 2a and b). Xanthoerythrophoroma
cells were typically densely packed with two types of
spherical or oval cytoplasmic organelles limited by a single
membrane. The smaller ones were completely filled with
amorphous substance. The larger ones were either empty or
contained amorphous electron-dense material loosely ar-
ranged in circular structures (Figure 2c and d). These vesicles
correspond to the described ultrastructure of larval and adult-
type pterinosomes that are responsible for the reddish and
yellowish color (Kamei-Takeuchi and Hama, 1971; Frost
et al., 1984). The appearance of the observed tumor-related
melanosomes or pigment-containing organelles is in sharp
contrast to the well defined and pigment-loaded mature
melanosomes or other pigment-containing organelles that
were previously described for normal fish pigment cells
(Riehl et al., 1984; Ferrer et al., 1999; Hirata et al., 2005).
Stable transgenic lines were established from the injected
G0 fish. Tumors in the stable lines showed the same
spectrum, and were of the same histology and ultrastructure
as the lesions in the G0 animals.
The comparison between heterozygous and homozygous
mitfHxmrk transgenic fish revealed a marked dosage effect.
Heterozygous fish first developed extended dark black spots
in the fins and the trunk at about 6–10 weeks of age.
According to Patton et al. (2005) and Gimenez-Conti et al.
(2001) they were classified as f-nevi or cutaneous hyperpig-
mentation. Furthermore, most of these transgenic fish showed
a hyperpigmentation of the xanthophore/erythrophore line-
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age, leading to intensive dark orange coloration of large areas
of the skin. A varying fraction (10–40%) developed exopyhtic
and/or invasive pigment tumors. This process could take up to
6 months after first appearance of hyperpigmentation.
In all homozygous fish, the pigmentation change started
much earlier, sometimes as early as 8–10 days post hatching.
Within 2–6 weeks, the hyperpigmented areas transformed to
malignant tumors. Thus, similar to the Xiphophorus model,
melanoma penetrance also reached 100% in the transgenic
medaka model. After a few weeks, most tumor-bearing fish
became weak, developed cachexia, and eventually died.
Signal transduction and gene expression of xmrk-induced
tumors
All tumors analyzed showed a high mRNA expression
(n¼28) and low to very high protein expression of the stably
integrated xmrk transgene (n¼ 10) (exemplarily shown in
Figures 3 and 4). Western blot analyses comparing the
activation state of known signal transducers in Xiphophorus
and medaka melanoma showed that Xmrk expression was
accompanied by activation of Akt, consistent with the known
stimulation of the Pi3 (phosphoinositide 3) kinase pathway
by Xmrk (Wellbrock et al., 1999). The well-established
Figure 1. Histology of pigment cell tumors in mitfHxmrk transgenic medaka. (a) Displays of macroscopic and microscopic patterns of exophytic
xanthoerythrophoroma. (a, upper image) 10-week-old female medaka (Carbio) with exophytically growing xanthoerythrophoroma. (a, lower image)
Xanthoerythrophoroma growing in the dermal compartment and locally invading the underlying trunk musculature (arrows). Nests of melanized tumor cells are
interspersed (Sc, scale). Bar¼ 50 mm. (b) Macroscopic and microscopic patterns of amelanotic uveal melanoma. (b, upper image)
5-month-old adult albino medaka (i-3) exhibiting unilateral exophthalmus and light brownish tumorous outgrowth around the eye. (b, lower image) Origin of the
tumor in the chorioidea. The histological structures of retina and optical nerve seem to be normal and show no sign of malignancy. Bar¼ 50mm. (b, insert) The
tumor cells are of epitheloid uveal melanoma cell type, forming parallel rows. Some of them are lightly pigmented, which is a typical feature of amelanotic
melanoma in tyrosinase-positive albino genotypes. Bar¼ 20 mm. (c) Macroscopic and microscopic patterns of invasive extracutaneous melanotic melanoma. (c,
upper image) 4-week-old juvenile medaka (Carbio) with melanotic tumor filling the abdomen and growing invasively into the musculature. (c, lower left image)
Melanoma metastasis in the liver. Bar¼ 40 mm. (c, lower right image) Melanoma growing in the intestinal mucosa (I), filling the body cavity and growing
invasively into the ovary (O). Bar¼ 100mm. (d) Macroscopic and microscopic patterns of perineural melanotic melanoma. (d, upper image) 11-week-old female
medaka (Carbio) with melanized tissue surrounding the neural tube (arrow). (d, lower image) Advanced stage of perineural melanoma growing progressively into
the abdomen and the dorsal trunk musculature. Kidney (K), vertebral bone with remnants of the chorda dorsalis (V), neural tube (NT). Bar¼ 150 mm. (d, insert)
Early stage of perineural melanoma consisting of heavily melanized differentiated cells that have not yet invaded the adjacent muscle. Bar¼ 40 mm.
www.jidonline.org 251
M Schartl et al.
Mutant EGFR-Induced Melanoma
activation of Mapk/Erk kinase and mitogen-activated protein
kinase (Mapk) by Xmrk (Wellbrock et al., 2002) was not so
evident in the transgenic model, as healthy medaka skin,
used as reference organ, already exhibits a considerable
activity of both signal transducers. Most striking was the
strong activation of Stat5 that went along with the level of
Xmrk expression in the tumors.
The fact that Xmrk signaling is the primary event inducing
pigment cell tumors in this transgenic model prompted us to
analyze whether genes, known to be relevant for human
melanomagenesis, are affected by Xmrk. In the tumors, no
significant transcriptional differences were recorded for the
growth inhibitory gene, cdkn2d, or the growth-promoting
genes, stat3, stat5, and b-raf (data not shown). In contrast,
there was a strong transcriptional upregulation of the pigment
cell-specific transcription factor mitf that went along with
xmrk expression (Figure 4a). Although melanoma and
xanthoerythrophoroma both displayed this upregulation on
RNA level, enhanced Mitf protein levels were only observed
in melanoma, whereas xanthoerythrophoroma had undetect-
able to low protein levels (Figure 4b). We also monitored
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Figure 3. Western blot analysis of Xiphophorus hybrid and transgenic
medaka tumors. Protein lysate of Carbio skin, xanthoerythrophoroma
(XE tumors) and melanoma was analyzed using western blot. Antibodies were
directed against Xmrk, phosphotyrosine (P-Tyr), phosphorylated MAPK/ERK
kinase (P-MEK), MAPK (P-MAPK), AKT (P-AKT), and STAT5 (P-STAT5).
After long exposition of the blots, an Xmrk-specific signal was also observed
in XE tumors #1 and #2 (not shown). The upper P-Tyr band (arrow) runs at the
same size as the Xmrk-specific band, suggesting that it represents
phosphorylated Xmrk. The upper AKT band is the specific one and is
indicated by an arrow. b-actin is used as loading control. Total levels of
STAT5 were similar between skin and pigment cell tumors from each species
(data not shown).
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Figure 4. Expression of xmrk, mitf, sox10b, and survivin 1 in tumors.
(a) Quantitative real-time RT-PCR analysis of xmrk, mitf, sox10b, and survivin
1 transcript levels in normal eye, muscle, skin, and in different pigment cell
tumor types of mitfHxmrk transgenic medaka. (b) Western blot of MITF in
control skin of healthy Carbio fish, xanthoerythrophoroma (XE tumor), and
melanoma. b-actin was used as loading control.
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Figure 2. Ultrastructure of melanoma and xanthoerythrophoroma.
(a) Melanoma cell with lobulated nucleus and nuclear pockets. The
cytoplasm is filled with immature melanosomes. (b) Incompletely melanized
premelanosomes with clumped or rod-like aggregates of melanin deposits.
(c) Tumor cell from a xanthoerythrophoroma with numerous vesicular
pigment organelles. (d) Pterinosomes of the larval type. For comparison with
the ultrastructure of normal fully differentiated pigment cells see Vielkind and
Vielkind (1970) and Riehl et al. (1984). Bars represent 4mm in (a), 1mm in
(b), 3mm in (c) and 1mm in (d). NP, nuclear pocket, PM, premelanosome,
PT, pterinosome.
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another transcription factor playing an important role in
pigment cell development, sox10, which can induce mitf
expression in zebrafish. Surprisingly, it was highly upregu-
lated in all exophytic xanthoerythrophoroma, but only
slightly in some uveal tumors and invasive extracutaneous
melanoma (Figure 4a). Thus, it did not correlate with Mitf
protein expression. This leads to the conclusion that Mitf
is regulated by posttranscriptional mechanisms in this
melanoma model.
The antiapoptotic factor, BCL-2 plays an important role in
human melanomagenesis and is considered as a target for the
treatment of malignant melanoma (Tarhini and Kirkwood,
2007; Poeck et al., 2008). In some melanoma and
xanthoerythrophoroma from mitfHxmrk medaka, an upregu-
lation of medaka bcl-2 on RNA level was visible (Figure 5a).
However, protein levels were only significantly raised in
melanoma tissue (Figure 5b).
We also monitored expression of several progression
markers described for human melanoma, namely integrin
av, N-cadherin, cyclin D1, telomerase, and survivin (Hodi,
2006). When comparing healthy tissue with pigment cell
tumors, the only consistently upregulated gene in melanoma
(except uveal melanoma) was survivin 1, one of the two
survivin genes occurring in fish (Figure 4a).
Evidence for genetic modifiers
Most xmrk transgenic lines were established using the Carbio
strain of medaka, which is a non-inbred line and possesses a
mixed genetic background. Here, various types of pigment
cell tumors were observed, with xanthoerythrophoromas
displaying the highest frequencies, followed by extracuta-
neous melanoma, and then by uveal melanoma that only
occurred rarely. We have started to cross the transgene into
different medaka lines of defined genetic background.
Already after two generations, we observed strong differences
in the tumor phenotypes depending on the genetic back-
ground. In the CabR’ andHB32C background, the penetrance
was 100% in homozygous transgenics, similar to Carbio.
Within each line the tumor phenotype was stereotyped
with respect to tumor onset, pathophysiological growth
characteristics, and location (Figure 6a). CabR’ fish contain-
ing the xmrk transgene developed almost exclusively massive
exophytic xanthoerythrophoromas. Only at terminal stages
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Figure 5. Expression of bcl-2 in tumors. (a) Quantitative real-time RT-PCR
analysis of bcl-2 transcript levels in normal eye, intestine, skin, and in
different pigment cell tumor types of mitfHxmrk transgenic medaka. Ef1a was
used as reference gene. (b) Western blot of BCl-2 in control skin of healthy
Carbio fish, xanthoerythrophoroma (XE tumor), and melanoma. b-actin was
used as loading control.
Figure 6. MitfHxmrk transgenic medaka showing genetic background-
dependent differences in tumor development. (a) Cutaneous exophytic
xanthoerythrophoroma in CabR’ strain. (b) Extracutaneous invasive melanotic
melanomas in HB32C strain. (c, d)MitfHxmrk transgenic p53/medaka with
typical focal development of fast growing nodular tumors.
(c) Xanthoerythrophoroma and (d) melanotic melanoma.
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these displayed different degrees of invasiveness into the
underlying trunk musculature. About 2–5% of the fish had
nodular or invasive melanoma and these mostly occurred in
addition to the xanthoerythrophoroma.
In the HB32C genetic background, on the contrary, the
absolute majority of tumors were classified as invasive
extracutaneous melanoma, with an onset at 4–6 weeks that
occasionally progressed to large nodules breaking through
the integument. Xanthoerythrophoroma were extremely rare
in this strain (Figure 6b).
In the albino (i-3) genetic background, the xmrk carrying
fish showed a hyperpigmentation of xanthophores that rarely
developed into tumors. About 30% developed extracuta-
neous, weakly pigmented melanoma from the intestine.
Strikingly, up to 40% of this strain exhibit unilateral or
bilateral eye melanoma. By histology, these tumors were
shown to emerge from the chorioidea and not from the retinal
pigment epithelium (Figure 1c).
The mitfHxmrk transgene was also crossed into a p53-
negative genetic background (Taniguchi et al., 2006). Neither
heterozygous nor homozygous p53-mutant fish displayed,
during the initial phase of tumorigenesis, a marked difference
in tumor onset or any other pathological feature compared
with the p53 wild-type Carbio background. However, when
the fish reached adulthood, all homozygous p53/ fish
developed one to several rapidly growing exophytic or
invasive nodular tumors that reached a strikingly large size
(Figure 6c and d). These tumors most likely arose from
already existing melanoma or xanthoerythrophoroma, and
did not develop de novo from non-tumorous tissues. So far
we did not observe this phenomenon in the p53þ /
mitfHxmrk fish after more than 1 year of observation.
DISCUSSION
The xmrk gene is a highly potent melanoma-inducing
oncogene derived from the Xiphophorus EGFR gene, which
leads to neoplastic transformation of a variety of cell types of
fish and mammalian origin. EGFR and related growth factors
are expressed in normal human melanocytes, and stimulation
with ligand promotes their migration (Gordon-Thomson et al.,
2001; Stove et al., 2003; Gordon-Thomson et al., 2005).
They are also expressed in melanoma cells, and are
associated with melanoma proliferation in vitro (Stove
et al., 2003; Gordon-Thomson et al., 2005; Funes et al.,
2006) and with melanoma maintenance in vivo (Bardeesy
et al., 2005). Here, we show that expressing xmrk under the
control of a pigment cell-specific promoter is sufficient to
induce melanoma in medaka. Similar to human pigment
cells, but unlike murine ones, fish pigment cells mainly reside
in the basal layer of the epidermis. All cutaneous melanoma
originate from there. The xmrk-induced melanoma observed
here show striking ultrastructural and histopathological
similarities to human melanoma. As in humans, the fish
melanoma cells contain strongly deformed nuclei and
immature melanosomes, which are characteristic for poorly
differentiated melanoma. Metastases to the liver are also
often observed (Vielkind and Vielkind, 1970; Riehl et al.,
1984; Gimenez-Conti et al., 2001). Thus, this first stable
transgenic fish melanoma model provides an useful addi-
tional tool for studies on genetic and biochemical require-
ments for this cancer type. Importantly, we also established
strains that develop uveal and extracutaneous melanoma,
depending on their genetic background. Uveal melanomas
are also observed in human patients. The mostly used murine
uveal melanoma model relies on injection of uveal melano-
ma cells of murine or human origin into the eye, thus
allowing to monitor maintenance and progression, but not
initial development of the tumor (Notting et al., 2006; Yang
et al., 2008). In addition, there is a transgenic murine model
for pigmented ocular neoplasm, in which large T antigen,
driven by the Tyrp promoter, is causative for the disease (De
la Houssaye et al., 2008). However, owing to the induction of
known melanoma-relevant pathways and its full passage
through all steps necessary for development of real uveal
melanoma, the medaka model is the first tumor model that
carries the potential to recapitulate this specific melanoma
subtype. The presence of different pigment cell tumor
phenotypes in our model system indicates a genotype-
dependent action of tumor modifier genes and will allow
their identification using genetic and large-scale mutagenesis
approaches. Remarkably, this previously unknown melano-
ma model also shows a pronounced metastatic phenotype,
which is less evident in the original Xiphophorus model. The
possibility of influencing pathological features by differences
in the genetic background combined with the availability of
genomic tools and transgenic technology opens previously
unreported opportunities for an in-depth analysis of the
molecular mechanisms of melanoma development that were
not available before.
The new melanoma model was used to evaluate in vivo
pigment cell tumor-relevant molecules. We found that
activation levels of Stat5 strictly correlated with Xmrk
expression levels in both xanthoerythrophoroma and mela-
noma, the latter displaying the highest activation. In
comparison, Mek, Mapk, and Akt also occurred in their
activated forms in non-melanoma fish skin, although usually
in lower levels. It is possible that the slight increase of
activated Akt in melanoma is sufficient to induce aberrant
growth signaling and melanoma progression, as it might
overcome a certain critical threshold level. In addition, the
Mek/Mapk and Pi3K/Akt pathways might be important in
early stages of melanoma formation, and their activation
might be less prominent in advanced melanoma that were
used for western blot analysis.
However, Stat5 seems to play a dominant role, at least in
already developed pigment cell tumors. The importance of
Stat5 for Xmrk-driven melanoma in Xiphophorus was inferred
from cell culture studies, as it takes part in xmrk-transformed
mouse melanocytes in antiapoptotic and proliferative signal-
ling (Wellbrock et al., 1998; Baudler et al., 1999; Morcinek
et al., 2002). In addition, in human melanoma cell lines,
STAT5 was shown to be involved in both survival and
interferon resistance (Wellbrock et al., 2005; Mirmoham-
madsadegh et al., 2006).
An upregulation of Mitf protein was only observed in
Xmrk-induced melanoma compared with that in healthy skin.
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In xanthoerythrophoroma, Mitf levels were strongly de-
creased. The role of this transcription factor in melanoma
development is not entirely understood. On the one hand, it
seems to be an antiproliferative factor in general (Carreira
et al., 2005) and in melanoma cells with upregulated RAS/
RAF/MAPK signalling. However, a certain threshold level
needs to be retained to stimulate proliferation and/or survival
(Carreira et al., 2006; Wellbrock and Marais, 2005). On the
other hand, high-level amplification of the MITF gene in
metastatic melanoma correlated with poor prognosis. In vitro
studies showed a cooperative effect of MITF with
mutant BRAF in the transformation of primary melanocytes
(Garraway et al., 2005). BRAFV600E can also enhance MITF
transcription in melanoma, thus effecting expression of the
crucial cell cycle kinases, CDK2 and CDK4 (Wellbrock et al.,
2008). In addition, upregulation of Mitf protein could have a
tumor promoting effect, as in humans, the antiapoptotic
factor BCL-2 is a direct MITF target gene (McGill et al., 2002).
Our in vivo data support the previous in vitro-based
hypothesis that Mitf might play a pro-tumorigenic role—at
least in the more malignant melanoma.
When we monitored Bcl-2 in medaka pigment cell
tumors, we found a correlation between Mitf and Bcl-2
protein, which was aberrantly present in melanoma, but not
in xanthoerythrophoroma. Both are more strongly regulated
by posttranscriptional than by transcriptional mechanisms in
medaka tumors. McGill et al. (2002) discussed a specific role
for BCL-2 in the protection against chemical stress that is
associated with melanin synthesis, which could explain the
observed differences between melanoma and xanthoerythro-
phoroma. A possible involvement of Mitf or Bcl-2 in the more
malignant phenotype of the melanoma can now be addressed
in future studies.
The comparable activation levels of MAPK in melanoma
and medaka skin, and the high mRNA level ofmitf that is not
reflected by a similar increase in protein show that high MAPK
activity and mitf expression levels may be useful markers for
melanoma, but are not necessarily similarly important on the
functional level for the development of the tumor.
Another interesting observation was the high expression of
survivin 1 in one invasive melanoma and in XE tumors, but
not in healthy tissue. Owing to the lack of a fish-specific
survivin antibody, it was not possible to examine protein
expression. However, we noted that only one of the two
survivin genes was regulated. An involvement of survivin 1 in
angiogenesis was shown during zebrafish development (Ma
et al., 2007). In human melanoma, survivin is often strongly
expressed, whereas it is downregulated in normal human
melanocytes by a mechanism involving p53, Rb, and E2F2
(Raj et al., 2008). It has a dual function in either preventing
apoptosis (when localized to mitochondria) or mediating cell
cycle progression (when associated with the chromosomal
passenger complex). Most likely, both tasks are fulfilled in
melanoma (Ding et al., 2006; Liu et al., 2006). In melanoma
patients, survivin expression is even associated with disease
recurrence and poor survival (Piras et al., 2007).
A melanoma model for zebrafish was published earlier by
Patton et al. (2005). Here, melanomas were produced by
transgenic expression of human BRAFV600E under control of
the homologous mitf/nacre promoter. The V600E mutant is
frequently found in human melanoma and nevi. It leads to a
constitutive hyperactive kinase activity (Wan et al., 2004) and
consequently to a high MAP kinase activity, which is a
hallmark of many melanomas (Satyamoorthy et al., 2003).
The oncogenic BRAF mutation is comparable with the
situation following growth factor receptor signaling, includ-
ing the EGFR and Xmrk. However, unlike the xmrk transgenic
medaka, expression of activated BRAFV600E alone in zebrafish
resulted in benign hyperpigmentation spots, called f-nevi.
Only when mutated BRAF was highly overexpressed in
pigment cells of p53-deficient zebrafish (Berghmans et al.,
2005), malignant melanoma developed. The zebrafish data
support the observation that BRAF activation in humans is not
sufficient for melanoma formation (Michaloglou et al., 2005),
but presumably induces a senescence-like cell cycle arrest
when present in nevi (Pollock et al., 2003).
A common feature of the zebrafish and medaka models is
that in both cases a p53 effect on tumor development is
noted. However, in the transgenic medaka, absence of a
functional p53 protein had no effect on the onset of
melanoma formation and the degree of malignancy during
early phases of the disease. Instead, the absence of p53
promoted the development of massive focal outgrowth or
invasion, indicating its importance for melanoma progres-
sion. Thus, in medaka, the absence of dysfunctional p53 is
not a precondition for malignant melanoma development in
general. The role of p53 deficiency for melanoma needs to be
elucidated further in both models, as p53 itself is rarely
mutated in human melanoma development (for review see
Levy et al., 2006; Takata and Saida, 2006).
Xmrk as a receptor tyrosine kinase is strategically placed at
the top of several growth-promoting signaling pathways. It
has been shown to activate, beside the RAS/RAF/MAPK
cascade, the PI3 kinase, PLC-gamma, STAT5, FYN, and
the focal adhesion kinase, all of which are involved in
mediating the complex fully malignant neoplastic phenotype
(Wajapeyee et al., 2008). Thus, the stronger oncogenicity of
Xmrk compared with that of BRAFV600E may be simply
explained by its wider downstream activation capacity.
We report here the first stable transgenic melanoma model
in a small aquarium fish species, in which all gene carriers
develop a tumor. The stable xmrk transgenic lines give a very
stereotyped tumor development with an early onset during
larval stages. They are, therefore, ideally suited for large-scale
testing of chemical compound library and for mutagenesis
screens to identify tumor modifier genes.
MATERIALS AND METHODS
Fish
All animal studies have been approved by the authors’ Institutional
Review Board (Animal Welfare Officer of the University of
Wurzburg). Adult fish were maintained under standard conditions
(Kirchen and West, 1976) with an artificial photoperiod (10 hours of
darkness, 14 hours of light) to induce reproductive activity. Clusters
of fertilized eggs were collected 0.5–1 hour after the onset of light
and kept in a rearing medium containing 0.1% NaCl, 0.003% KCl,
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0.004% CaCl2 2H2O, 0.016% MgSO4 7H2O, and 0.0001%
methylene blue. Embryos were staged according to Iwamatsu (2004).
Fish from the following strains were used: Carbio (outbred strain,
mixed genetic background of southern medaka), CabR’ (closed
colony inbred strain carrying the R0, variegated, locus), albino i-3,
HB32C. (For detailed information on these strains see http://
www.shigen.nig.ac.jp/medaka). In addition, the p53/ strain was
used, which owing to a point mutation has a premature stop codon
in the p53 gene (E241X) and consequently lacks expression of a
functional p53 protein (Taniguchi et al., 2006). The p53/ tilling
mutation is kept in the CabR’ genetic background.
Isolation of the medaka mitf promoter and construction of
expression vectors
To isolate a fragment of the medaka mitfa promoter, a PCR was
performed using genomic DNA of the Carbio strain as template. The
primers used for amplification of 1057 bases upstream of the mitfa
gene introduced an ApaI site and an NcoI site. The product was cut
with ApaI/NcoI and cloned into the ApaI/NcoI-digested 3.9 kbp
fragment of plasmid I-Sce-I-pCSKAHdeltaDMHGFP (Hornung et al.,
2007), containing the enhanced green fluorescent protein open
reading frame with the SV40 polyA site. This resulted in plasmid
mitfHGFP. Injection of this plasmid into medaka embryos confirmed
pigment cell-specific expression of transgenes under the control of
this promoter (data not shown). For constructing the mitfHxmrk
plasmid, the enhanced green fluorescent protein open reading frame
was excised from mitfHGFP by digestion with NcoI/Bsr6I. The 3.6 kb
XbaI/DraI cDNA fragment from xmrk was excised from pBIIG4
(Malitschek et al., 1994) and inserted into the remaining vector
containing the mitf promoter and the SV40 polyA site. Constructs
used for this study were verified by sequencing.
Production of stable transgenic medaka
For the generation of stable transgenic lines, the meganuclease
protocol (Thermes et al., 2002) was used. Briefly, approximately
15–20pg of total vector DNA in a volume of 500 pl injection solution
containing I-SceI meganuclease was injected into the cytoplasm of
one-cell stage medaka embryos (strains: Carbio, CabR’, i-3, HB32C,
p53/). Adult F0 fish were mated with each other and the offspring
was tested for the presence of the transgene by PCR from pooled
hatchlings. Siblings from positive F1 fish were raised to adulthood
and tested by PCR from dorsal fin clips, as described (Altschmied
et al., 1997).
Altogether, 1,139 Carbio and 801 albino (i-3) embryos were
injected with the construct, giving rise to 105 (Carbio) and 51 (i-3)
adult individuals. Eight (Carbio) and three (i-3) of these were carriers
of the transgene. Stable lines were established, three of which (two
Carbio and one i-3) showed a pigmentation phenotype.
Histology
For histological analysis, fish were fixed in Bouin’s fixative (satur-
ated picric acid in H2O: formaldehyde (37%): glacial acidic
acid, 15:5:1), transferred to fixative solution (1 phosphate-
buffered saline, 10% formaldehyde (3%)), and embedded in
paraffin. Sections of 5mm thickness were stained with hematox-
ylin/eosin.
For electron microscopy, pieces of tumor tissues were washed with
phosphate-buffered saline and fixed (2.5% glutaraldehyde, 50mM
cacodylate (pH 7.2), 50mM KCl, and 2.5mM MgCl2) overnight at 41C.
Thereafter, they were washed five times with 50mM cacodylate buffer
(pH 7.2) and post-fixed for 3–4hours with 2% OsO4 in 50mM
cacodylate (pH 7.2) buffer. After five washing steps with H2O,
embryos were stained with 2% uranylacetate overnight and washed
again with H2O. After gradual dehydration with ethanol, they were
transferred to propylenoxid and subsequently embedded in Epon 812
(Serva, Heidelberg, Germany). Sections were analyzed using an EM10
from Zeiss (Wetzlar, Germany).
RNA expression analysis
Total RNA was extracted from pooled healthy skin or organs, as well
as individual tumors using TRIZOL (Invitrogen, Karlsruhe, Germany)
or Total RNA Isolation Reagent (ABgene, Hamburg, Germany)
according to the supplier’s recommendation. After DNase treatment,
reverse transcription was performed from total RNA using Super-
script II Reverse Transcriptase (Invitrogen) or RevertAid First Strand
Synthesis kit (Fermentas, St Leon-Rot, Germany) and random
hexamer primers, according to the manufacturer’s instructions.
cDNA from 15ng of total RNA for ef1a and from 50ng of total
RNA for all other transcripts was used for real-time PCR (primer
sequences, are made available on request) using SYBR Green
reagent, and amplification was monitored with i-Cycler (Bio-Rad,
Munich, Germany). All results are averages of at least two
independent reverse transcription reactions and 2–5 PCR experi-
ments from each such reaction. For quantification, data were
analyzed by the delta Ct method (Simpson et al., 2000) and
normalized to the housekeeping gene ef1a mRNA.
For spot check, negative control RNA (not reversely transcribed),
was used in the PCR reaction. Data are presented as mean±standard
deviation. Changes in mRNA expression were tested using an
independent t-test with significance level Pp0.05.
Protein analysis
After dissection, melanoma or control tissue was rinsed with
phosphate-buffered saline and homogenized in protein lysis buffer
(50mM HEPES (4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid)
(pH 7.5), 150mM NaCl, 1,5mM MgCl2, 1mM EGTA, 10% glycerol,
1% Triton, 10 mgml1 aprotinin, 10 mgml1 leupeptin, 200 mM
Na3VO4, 1mM PMSF (phenylmethanesulfonylfluoride), and 100mM
NaF). A total of 50 mg of protein lysate was separated by SDS/PAGE
and transferred to nitrocellulose according to standard western
blotting protocols. Primary antibodies against the following
proteins were used: phosphotyrosine P-Tyr-100, phospho-ERK1/2
Tyr202/204, phospho-MAPK/ERK kinase1/2 Ser217/221, phospho-
AKT Thr308, phospho-STAT5 Tyr694 (all from Cell Signaling
Technology, New England Biolabs, Frankfurt, Germany), beta-actin
(C4), BCL-2 (C21) (Santa Cruz Biotechnology, Heidelberg, Ger-
many), and MITF (Aviva Systems Biology, San Diego, CA). Anti-mrk
is a rabbit polyclonal antiserum obtained by immunization with a
polypeptide representing a C-terminal part of Xmrk (‘‘pep-mrk’’)
(Malitschek et al., 1994).
As secondary antibodies, horseradish peroxidase-coupled anti-
mouse (Pierce, Rockford, IL), anti-rabbit (Bio-Rad), or anti-goat
(Abcam, Cambridge, UK) IgG were used.
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